Pemazyre 13,5 mg, comprimés

7680681430056 CH-68143 Tabletten

Associated product:

PEMAZYRE cpr 13.5 mg 14 pce
Pemazyre 13,5 mg, comprimés
Pemazyre 13,5 mg, comprimés
Pemazyre 13,5 mg, comprimés
1 / 3
google

Article details

Package size
14
Selling units
14
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/08/2025
Patient information leaflet
Français
13/08/2025
Patient information leaflet
Italien
13/08/2025
Summary of Product Characteristics
Allemand
13/08/2025
Summary of Product Characteristics
Français
13/08/2025
Summary of Product Characteristics
Italien
13/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
13.5 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.528 MG Substance HBESI
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 7124.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2022

Authorization holder

Incyte Biosciences International

1110 Morges

Authorization information

Swissmedic authorization number
68143
Drug name
Pemazyre, comprimés
Galenic form
TAB
ATC Code
L01EN02
Authorization status
Z
Dispensing category
A
First authorization
13/07/2021
Authorization expiration date
23/07/2030
IT Number
07.16.1.
Domain
Human medicine

Package details

Description (FR)
PEMAZYRE cpr 13.5 mg 14 pce
Description (DE)
PEMAZYRE Tabl 13.5 mg 14 Stk
Market launch
13/07/2021
Narcotic (BTM)
No

Other package sizes (5)

PEMAZYRE cpr 4.5 mg 14 pce
14 TABL
GTIN: 7680681430018
View
None
28 TABL
GTIN: None
Not in V1
PEMAZYRE cpr 9 mg 14 pce
14 TABL
GTIN: 7680681430032
View
None
28 TABL
GTIN: None
Not in V1
None
28 TABL
GTIN: None
Not in V1